Methanone,(1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]-,hydrochloride (1:1) cas no:132907-72-3
Synonyms: Methanone,(1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-,monohydrochloride, (R)-;Methanone,(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]-,monohydrochloride (9CI);(-)-(R)-5-[(1-Methyl-1H-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazolemonohydrochloride;(R)-(-)-Ramosetron hydrochloride;Irribow;Ramosetronhydrochloride;YM 060;
NameMethanone,(1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]-,hydrochloride (1:1)
CAS132907-72-3
SynonymsMethanone,(1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-,monohydrochloride, (R)-;Methanone,(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]-,monohydrochloride (9CI);(-)-(R)-5-[(1-Methyl-1H-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazolemonohydrochloride;(R)-(-)-Ramosetron hydrochloride;Irribow;Ramosetronhydrochloride;YM 060;
Molecular FormulaC17H18ClN3O
Molecular Weight315.8
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| dog |
LD |
intravenous |
> 30mg/kg (30mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE |
Oyo Yakuri. Pharmacometrics. Vol. 47, Pg. 117, 1994. |
| dog |
LD |
oral |
> 60mg/kg (60mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
GASTROINTESTINAL: NAUSEA OR VOMITING |
Arzneimittel-Forschung. Drug Research. Vol. 45, Pg. 760, 1995. |
| mouse |
LD50 |
intravenous |
90mg/kg (90mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 27, Pg. 652, 1996. |
| rat |
LD50 |
intravenous |
151mg/kg (151mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) |
Oyo Yakuri. Pharmacometrics. Vol. 47, Pg. 105, 1994. |
| rat |
LD50 |
oral |
1264mg/kg (1264mg/kg) |
? |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 1048, 1999. |
